Skip to main content

MJFF Publications

5821 - 5830 of 7665 Results
Title
Year
  • Year
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • 2017
  • RESTRICTED
    Title: Disentangling the neural correlates of corticobasal syndrome and corticobasal degeneration with systematic and quantitative ALE meta-analyses
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0012-6
    Citation Count: 29
  • RESTRICTED
    Title: Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesia
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.13997
    Citation Count: 33
  • RESTRICTED
    Title: Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26976
    Best OA location URL:
    Citation Count: 29
  • RESTRICTED
    Title: Kinetin Riboside and Its ProTides Activate the Parkinson’s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.6b01897
    Citation Count: 72
  • RESTRICTED
    Title: LRRK2 levels in immune cells are increased in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0010-8
    Citation Count: 185
  • RESTRICTED
    Title: The prodromal phase of leucine‐rich repeat kinase 2–associated Parkinson disease: Clinical and imaging Studies
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26964
    Best OA location URL:
    Citation Count: 51
  • RESTRICTED
    Title: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1616874114
    Citation Count: 62
  • RESTRICTED
    Title: Cortical surface‐based threshold‐free cluster enhancement and cortexwise mediation
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.23563
    Citation Count: 19
  • RESTRICTED
    Title: Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12478
    Citation Count: 63
  • RESTRICTED
    Title: Photobiomodulation-induced changes in a monkey model of Parkinson’s disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatum
    Journal Name: Experimental Brain Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00221-017-4937-0
    Best OA location URL:
    Citation Count: 42
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.